LifeVantage outlines $185M–$200M revenue target and new $60M buyback amid GLP-1 headwinds and LoveBiome integration
Lifevantage Corporation Common Stock (Delaware) · PHARMACEUTICAL PREPARATIONS · Now $9.43
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS